Glycans to improve efficacy and solubility of protein aggregation inhibitors
Ashim Paul, Daniel Segal, Elsa Zacco
Department of Molecular Microbiology and Biotechnology, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Ramat Aviv, Tel Aviv 6997801, Israel (Paul A, Segal D)
RNA Central Lab, Center for Human Technologies, Istituto Italiano di Tecnologia, 16152 Genova, Italy (Zacco E)
Online:2021-11-15
Published:2021-04-13
Contact:
Elsa Zacco, PhD, elsa.zacco@iit.it.
Supported by:
The present work was partially supported by the Israel Ministry of Science and the Alliance Family Trust (to DS). AP is recipient of a fellowship from the Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease (APPD). EZ has received funding from the MINDED fellowship of the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 754490.
Ashim Paul, Daniel Segal, Elsa Zacco. Glycans to improve efficacy and solubility of protein aggregation inhibitors[J]. Neural Regeneration Research, 2021, 16(11): 2215-2216.